A Polysaccharide Extracted from Agaricus bisporus and Its Preparation Method and Application

The polysaccharide extracted from Agaricus bisporus, prepared through staged compound enzymatic hydrolysis and chromatographic purification, overcomes the shortcomings of existing chemical drugs in the treatment of depression, achieving a natural and safe antidepressant effect, and possessing significant anti-anxiety and antidepressant activity.

CN123106939APending Publication Date: 2026-11-17YIXING INST OF FOOD & BIOTECHNOLOGY CO LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202611480510.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-09-22
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

Existing chemical drugs for treating depression suffer from problems such as long onset of action, limited cure rate, high relapse rate, and significant toxic side effects. There is an urgent need to develop natural antidepressant active substances, and there is a lack of research on the intervention and improvement of depression by polysaccharides extracted from Agaricus bisporus.

Method used

A homogeneous Agaricus bisporus enzyme-extracted polysaccharide was prepared by using a staged compound enzymatic hydrolysis process combined with cellulose column and dextran gel column chromatography purification, which significantly improved anxiety and depression-like behaviors induced by chronic unpredictable mild stress.

Benefits of technology

Polysaccharides extracted from Agaricus bisporus significantly improve depressive-like behaviors with no obvious toxic side effects. They possess natural and safe anti-anxiety and antidepressant activities, providing a material basis for the development of natural drugs.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN123106939A_ABST
    Figure CN123106939A_ABST
Patent Text Reader

Abstract

This invention relates to a polysaccharide extracted from Agaricus bisporus, its preparation method, and its application, belonging to the field of biomedical technology. This invention utilizes a staged complex enzymatic hydrolysis process, combined with cellulose column and dextran gel column chromatography purification, to obtain a homogeneous polysaccharide extracted from Agaricus bisporus. This polysaccharide can significantly improve depressive-like behaviors such as anxiety, behavioral despair, and anhedonia induced by chronic, unpredictable, mild stress, exhibiting anti-anxiety and antidepressant activities. Furthermore, this polysaccharide has no significant in vivo toxic side effects and possesses the advantage of being naturally safe.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of biomedical technology, and in particular relates to a polysaccharide extracted from Agaricus bisporus, its preparation method and application. Background Technology

[0002] Depression is a common mental illness characterized by persistent and severe negative emotions, often accompanied by physical symptoms such as fatigue, weakness, and sleep disturbances. It is not merely a mental disorder but can also trigger multiple pathological changes, potentially leading to neurodegenerative diseases, cardiovascular diseases, and abnormal glucose metabolism, among other underlying serious conditions. Currently, depression affects a wide range of people, with a large number of sufferers. It not only severely damages the physical and mental health of patients and disrupts normal life, but also imposes a heavy economic burden on society, making it a major public health concern worldwide.

[0003] Currently, clinical treatment for depression primarily relies on chemically synthesized antidepressants, with mainstream medications including tricyclic antidepressants, selective serotonin reuptake inhibitors (SSRIs), and monoamine oxidase inhibitors (MAOIs). However, existing chemical drugs suffer from unavoidable clinical limitations, generally exhibiting long onset of action, limited clinical cure rates, and high relapse rates. Some drugs also have certain toxic side effects, making long-term safe use difficult, which significantly restricts the clinical efficacy and application scenarios of depression treatment. Given the numerous drawbacks of traditional drugs, the development of safe, effective, and low-side-effect natural antidepressant active substances has become a new research hotspot in the field of mental illness treatment.

[0004] Button mushrooms are the most widely cultivated edible fungus globally, possessing both high nutritional value and medicinal potential. This edible fungus is rich in nutrients, containing polysaccharides, polyphenols, high-quality protein, various vitamins, and functional active compounds such as ergothioneine, making it a high-quality natural food source. Furthermore, the medicinal effects of button mushrooms have long been recorded in traditional texts. The *Compendium of Materia Medica* explicitly records its medicinal effects in regulating the stomach and intestines, and in relieving phlegm and promoting digestion. Due to its excellent biological activity and natural safety, its medicinal development value has attracted widespread attention within the industry.

[0005] Polysaccharides are one of the core functional active components of Agaricus bisporus, consistent with classic edible fungi active polysaccharides such as Lentinus edodes. Various bioactive polysaccharide components can be isolated and purified from Agaricus bisporus, and research on their structure-activity relationships and functions continues to advance. Existing studies have confirmed that Agaricus bisporus polysaccharides extracted using different processes possess differentiated bioactivities, with Agaricus bisporus enzyme-extracted polysaccharides exhibiting a unique monosaccharide composition system. Current research has verified that these polysaccharides can optimize the body's antioxidant levels and improve liver-related indicators. Furthermore, different glucan components derived from Agaricus bisporus have been shown to possess various pharmacological activities, including anti-tumor activity, inhibition of lipogenesis, and anti-obesity activity, demonstrating broad potential for natural drug development.

[0006] Although basic research and functional exploration of Agaricus bisporus enzyme-extracted polysaccharides are progressing in depth, there are currently no publicly available research reports on the activity and application of this polysaccharide in the intervention and improvement of mental illnesses such as depression. There is an urgent need for the development of antidepressant natural products, and the anti-anxiety and antidepressant activities of Agaricus bisporus enzyme-extracted polysaccharides represent a completely new research gap.

[0007] Based on this, the present invention is proposed. Summary of the Invention

[0008] To address the aforementioned technical problems, this invention provides a method for preparing and applying a polysaccharide extracted from Agaricus bisporus. Through a staged enzymatic hydrolysis process combined with purification by cellulose column and dextran gel column chromatography, a homogeneous polysaccharide extracted from Agaricus bisporus is obtained. This polysaccharide can significantly improve depressive-like behaviors such as anxiety, behavioral despair, and anhedonia induced by chronic, unpredictable, mild stress, exhibiting anti-anxiety and antidepressant activities. Furthermore, this polysaccharide has no significant in vivo toxicity and possesses the advantage of being naturally safe.

[0009] The first objective of this invention is to provide a method for preparing polysaccharides extracted from Agaricus bisporus, comprising the following steps: S1. Disperse the button mushroom ultrafine powder in water, first add cellulase and xylanase for the first stage of enzymatic hydrolysis, then add heat-resistant α-propanase. Amylase was used for the second stage of enzymatic hydrolysis, then papain was added for the third stage of enzymatic hydrolysis and enzyme inactivation, followed by the addition of saccharifying enzyme for the fourth stage of enzymatic hydrolysis and enzyme inactivation again, and centrifugation was used to obtain the Agaricus bisporus complex enzyme extract. S2. The Agaricus bisporus complex enzyme extract described in S1 is concentrated by rotary evaporation. Ethanol is added dropwise under stirring to the first ethanol volume concentration. After standing, the supernatant is collected by centrifugation. Ethanol is added to the supernatant to the second ethanol volume concentration. After standing, the precipitate is collected by centrifugation. The precipitate is reconstituted with pure water and then dialyzed, concentrated under reduced pressure, and freeze-dried to obtain Agaricus bisporus enzyme extract crude polysaccharide. S3. The crude polysaccharide extracted from the button mushroom by enzymes in S2 is subjected to gradient elution on a cellulose column and water elution on a dextran gel column, and then freeze-dried to obtain the enzyme-extracted polysaccharide from the button mushroom.

[0010] In one embodiment of the present invention, in S1, the mass-to-volume ratio of the Agaricus bisporus ultrafine powder to water is (9-11) g: (280-320) mL; And / or, the pH of the enzymatic hydrolysis system is 4-6.

[0011] In one embodiment of the present invention, in S1, the amount of cellulase and xylanase used is independently 950 U / g-1050 U / g of Agaricus bisporus ultrafine powder; And / or, the temperature of the first stage of enzymatic hydrolysis is 55℃-65℃, and the time is 2.5h-3.5h; And / or, the amount of the heat-resistant α-amylase used is 4.5 μL / g to 5.5 μL / g of Agaricus bisporus ultrafine powder; And / or, the temperature for the second stage of enzymatic hydrolysis is 75℃-85℃, and the time is 0.5h-1.5h; And / or, the amount of papain used is 4.5 μL / g to 5.5 μL / g of Agaricus bisporus ultrafine powder; And / or, the temperature of the third stage of enzymatic hydrolysis is 55℃-65℃, and the time is 0.5h-1.5h; And / or, the amount of the saccharifying enzyme used is 48 μL / g-52 μL / g of Agaricus bisporus ultrafine powder; And / or, the fourth stage of enzymatic hydrolysis is carried out at a temperature of 55℃-65℃ for a time of 2.5h-3.5h.

[0012] In one embodiment of the present invention, in S1, the enzyme inactivation temperature is 95℃-105℃ and the time is 9min-11min; And / or, the temperature for the second enzyme inactivation is 95℃-105℃, and the time is 9min-11min.

[0013] In one embodiment of the present invention, in S2, the rotary evaporation concentration is concentrated to 1 / 4 to 1 / 6 of the original volume; And / or, the volume concentration of the first ethanol is 8%-12%; And / or, the volume concentration of the second ethanol is 65%-75%; And / or, the dialysis is performed using a dialysis bag with a molecular weight cutoff of 3000 Da-4000 Da, first dialyzing with flowing water for 1.5-2.5 days, and then dialyzing with ultrapure water for 0.5-1.5 days.

[0014] In one embodiment of the present invention, in S3, the cellulose column is a DEAE-52 cellulose ion exchange column; And / or, the gradient elution is performed sequentially with water, 0.25 mol / L sodium chloride solution, 0.5 mol / L sodium chloride solution, and 1 mol / L sodium chloride solution, at a flow rate of 0.6 mL / min-0.8 mL / min and a time of 380 min-420 min.

[0015] In one embodiment of the present invention, in S3, the dextran gel column is a Sephacryl-100 dextran gel column; And / or, the water elution flow rate is 0.6 mL / min-0.8 mL / min, and the time is 450 min-550 min.

[0016] A second objective of this invention is to provide a button mushroom enzyme-extracted polysaccharide prepared by the method described above, wherein the button mushroom enzyme-extracted polysaccharide has a molecular weight of 80kDa-95kDa and a polydispersity index of 1.0-1.2.

[0017] In one embodiment of the present invention, the mushroom polysaccharide extract comprises: 21wt%-24wt% arabinose, 3wt%-4wt% rhamnose, 26wt%-29wt% galactose, 3wt%-4wt% mannose, and 36wt%-40wt% galacturonic acid.

[0018] A third objective of this invention is to provide the application of the aforementioned Agaricus bisporus enzyme-extracted polysaccharide in the preparation of a medicine or food for the prevention or treatment of depression.

[0019] The technical solution of the present invention has the following advantages compared with the prior art: (1) The multi-enzyme combination sequential enzymatic hydrolysis process described in this invention utilizes cellulase and xylanase to disrupt the cell wall structure of *Agaricus bisporus*, facilitating the full dissolution of polysaccharide components and effectively increasing the yield of polysaccharides extracted from *Agaricus bisporus*. Simultaneously, it is compounded with heat-resistant α-hydroxylase. Amylase and papain can efficiently remove starch and protein impurities from samples. Combined with subsequent alcohol precipitation, dialysis, and then separation by cellulose column and purification by dextran gel column, homogeneous Agaricus bisporus enzyme-extracted polysaccharide can be obtained.

[0020] (2) The button mushroom enzyme-extracted polysaccharide described in this invention can significantly improve depression-like behavior induced by chronic unpredictable mild stress, and has antidepressant pharmacological activity, providing a material basis for the development of polysaccharide anti-anxiety and antidepressant drugs, and promoting the application research of natural active polysaccharides in the field of antidepressant drugs.

[0021] (3) The button mushroom enzyme extract polysaccharide described in this invention is a natural active substance. While exerting antidepressant effects, it has no obvious toxic side effects. It can make up for the technical defects of existing chemical antidepressants, which have limited efficacy and large side effects on the human body. It has outstanding advantages in the development of safe antidepressant functional drugs. Attached Figure Description

[0022] To make the content of this invention easier to understand, the invention will be further described in detail below with reference to specific embodiments and accompanying drawings, wherein: Figure 1 The images show the cellulose column elution curve (A) and the dextran column elution curve (B) of the crude polysaccharide extracted from Agaricus bisporus in Example 1 of this invention. Figure 2 The absolute molecular weight analysis diagram (A), molecular configuration diagram (B), and size exclusion chromatogram (C) of the polysaccharide extracted from Agaricus bisporus in Example 1 of the present invention are shown. Figure 3 The chromatograms (A) and (B) of the monosaccharide standard and sample of the polysaccharide extracted from Agaricus bisporus in Example 1 of this invention are shown. Figure 4 The Fourier transform infrared spectrum of the polysaccharide extracted from Agaricus bisporus in Example 1 of this invention; Figure 5 The graph shows the detection results of body weight (A), food intake (B), water intake (C), liver index (D), spleen index (E), and kidney index (F) of mice in test example 5 of the present invention. Figure 6 The images show the detection results of the mouse open field experiment in Test Example 6 of this invention: heat map (A), total mouse movement distance statistics (B), and mouse central area movement distance statistics (C). Figure 7 The results are shown in the following graphs: heat map (A), statistics of the number of times the mouse entered the open arm (B), and statistics of the time the mouse stayed in the open arm (C) in test example 7 of the present invention. Figure 8 The graph shows the results of the detection of the mouse's sugar water preference rate (A), immobility time in the tail suspension test (B), and immobility time in the forced swimming test (C) in Test Example 8 of the present invention. Detailed Implementation

[0023] The present invention will be further described below with reference to the accompanying drawings and specific embodiments, so that those skilled in the art can better understand and implement the present invention. Obviously, the described embodiments are only some embodiments of the present invention, and not all embodiments. It should be understood that the specific embodiments are only used to explain the present invention, but the embodiments are not intended to limit the present invention.

[0024] In this invention, unless otherwise stated, the technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention pertains.

[0025] In this invention, unless otherwise stated, the term "and / or" as used herein includes any and all combinations of one or more of the associated listed items.

[0026] In this invention, unless otherwise specified, the experimental methods used in the embodiments of this invention are conventional methods, and the materials and reagents used are commercially available unless otherwise specified.

[0027] In this invention, unless otherwise stated, the button mushroom ultrafine powder used in the embodiments is prepared as follows: the button mushrooms are dried overnight in an oven at 40°C, ground and passed through a 200-mesh sieve, and then further ground by an ultra-high-speed ultrafine pulverizer.

[0028] Example 1 The enzymatically extracted polysaccharide from Agaricus bisporus and its preparation method in this embodiment specifically include the following steps: S1. Weigh 10g of Agaricus bisporus ultrafine powder and place it in a beaker. Add 300mL of pure water and stir thoroughly. Place the beaker in an ultrasonic water bath and sonicate at 40℃ for 30min. Adjust the pH of the system to 5 using NaOH solution. Add cellulase and xylanase at a dosage of 1000U / g Agaricus bisporus ultrafine powder and enzymatically hydrolyze at 60℃ for 3h. Then add thermostable α-amylase at a dosage of 5μL / g Agaricus bisporus ultrafine powder. Enzymatic hydrolysis was performed at 80℃ for 1 hour; then, papain was added at a dosage of 5 μL / g of Agaricus bisporus ultrafine powder and enzymatic hydrolysis was performed at 60℃ for 1 hour. The enzyme was then inactivated at 100℃ for 10 minutes. After the system cooled, saccharifying enzyme was added at a dosage of 50 μL / g of Agaricus bisporus ultrafine powder and enzymatic hydrolysis was performed at 60℃ for 3 hours. The enzyme was then inactivated at 100℃ for 10 minutes. After extraction, the mixture was centrifuged and the supernatant was collected to obtain Agaricus bisporus complex enzyme extract. S2. The Agaricus bisporus complex enzyme extract was concentrated to 1 / 5 of its original volume using a rotary evaporator at 60℃. Anhydrous ethanol was added dropwise with stirring until the ethanol concentration reached 10%. After standing overnight, the supernatant was collected by centrifugation. Anhydrous ethanol was then added to the supernatant until the final ethanol concentration reached 70%. After standing overnight, the precipitate was collected by centrifugation. The precipitate was reconstituted with pure water and transferred to a dialysis bag with a molecular weight cutoff of 3500 Da. The precipitate was dialyzed with running water for 2 days and then with ultrapure water for 1 day. The polysaccharide solution after dialysis was concentrated under reduced pressure and then freeze-dried to obtain Agaricus bisporus enzyme-extracted crude polysaccharide. S3. Weigh 0.5g of crude polysaccharide extracted from Agaricus bisporus and dissolve it in 10mL of pure water. Treat the solution in a 55℃ metal bath for 1h, then stir overnight at 4℃. After centrifugation, collect the supernatant and load it onto a DEAE-52 cellulose ion exchange column. Elute sequentially with distilled water, 0.25mol / L sodium chloride solution, 0.5mol / L sodium chloride solution, and 1mol / L sodium chloride solution, controlling the elution flow rate at 0.7mL / min. Collect the solution at 5min / tube rate, for a total of 80 tubes. Combine the sugar-containing fractions and dialyze them in a dialysis bag for 36h, changing the solution every 12h. Sub-pure water; after dialysis, the sample solution was concentrated to about 5 mL and frozen at -80℃ for 1 day to obtain the Agaricus bisporus enzyme-extracted polysaccharide fraction purified by DEAE-52 chromatography; the Agaricus bisporus enzyme-extracted polysaccharide fraction was prepared into an aqueous solution with a concentration of 10 mg / mL and loaded onto a Sephacryl-100 dextran gel column, eluted with distilled water, and the elution flow rate was controlled at 0.7 mL / min. The solution was collected at 5 min / tube, for a total of 100 tubes. The sugar-containing fractions were combined and the resulting sugar-containing solution was frozen at -80℃ for 1 day to obtain Agaricus bisporus enzyme-extracted polysaccharide.

[0029] Test Example 1 Based on Example 1, during the DEAE-52 and Sephacryl-100 chromatography purification processes, 0.1 mL of the fraction was taken every four test tubes, and 0.9 mL of pure water and 1 mL of 5% phenol solution were added sequentially and vortexed to mix. Then, 5 mL of concentrated sulfuric acid was added and vortexed to mix again. The absorbance was measured using a blank sample as a reference, and an elution curve was plotted accordingly. The results are as follows. Figure 1 As shown. From Figure 1 It can be seen that multiple polysaccharide absorption peaks appeared during the cellulose ion exchange elution process, corresponding to the water elution and elution stages of sodium chloride solutions of different concentrations, respectively. This indicates that the crude polysaccharide extracted from Agaricus bisporus contains neutral polysaccharides as well as various acidic polysaccharides with different charges. As the sodium chloride concentration of the elution system increases, polysaccharide components with higher charge levels can be eluted sequentially. After the target components are separated by ion exchange, gel chromatography is performed, and sharp and concentrated elution signals are obtained, indicating that most of the purified polysaccharides have relatively uniform molecular weights.

[0030] Test Example 2 The polysaccharide extracted from *Agaricus bisporus* in Example 1 was dissolved in a 0.1 mol / L NaNO3 aqueous solution (containing 0.02% NaN3, w / w) to prepare a sample solution with a final concentration of 1 mg / mL. After filtration through a 0.45 μm pore size filter, the sample was detected using a gel permeation chromatography-differential-multi-angle laser light scattering system. The liquid chromatography system was a U3000, the differential detector was an Optilab T-rEX, and the laser light scattering detector was a DAWNHELEOS II. The chromatographic columns used were an Ohpak SB-805HQ (300×8 mm) and an Ohpak SB-803HQ (300×8 mm) gel size exclusion column connected in series. The column temperature was 45 °C, and the injection volume was 100 μL, using a 0.1 mol / L NaNO3 aqueous solution (containing 0.02% NaN3, w / w). NaN3 (w / w) was used as mobile phase A at a flow rate of 0.6 mL / min, with isocratic elution for 75 min. Chromatographic data processing was performed using ASTRA 6.1 software. Absolute molecular weight chromatograms, molecular configuration diagrams, and size exclusion chromatograms are shown below. Figure 2 ,in accordance with Figure 2 The molecular weights were calculated separately, and the results are shown in Table 1: Table 1

[0031] from Figure 2 As shown in Table 1, the number-average molecular weight M of the polysaccharide extracted from Agaricus bisporus is... n It is 83.959 kDa, and the weight-average molecular weight M w The polydispersity index (PDI) is 91.816 kDa. w / M n The PDI value was 1.094, very close to 1, indicating a narrow molecular weight distribution. The chromatographic elution signal showed a sharp and symmetrical single main peak with no obvious interference from other peaks. The change in molecular weight with elution time was consistent with the chromatographic peak process. At the same time, the corresponding change relationship between the molecular weight and the radius of gyration of polysaccharide molecules in the solution environment could be observed, indicating that the polysaccharide extracted from Agaricus bisporus has good uniformity.

[0032] Test Example 3 Take 2 mg of the polysaccharide extracted from Agaricus bisporus in Example 1 and place it in a brown bottle. Add 1 mL of 2 mol / L trifluoroacetic acid solution and heat at 120°C for 2 h in an incubator for hydrolysis. After the system cools to room temperature, transfer the hydrolysate to an evaporating dish and repeatedly add anhydrous ethanol under a 70°C water bath to remove trifluoroacetic acid. Dry to complete the acid hydrolysis of the polysaccharide sample. After PMP derivatization, the hydrolysate is detected using a high-performance liquid chromatography system equipped with a Kromasil 100-5C column. The mobile phase is phosphate buffer containing acetonitrile (pH 7.30, concentration 0.1 mol / L, volume ratio of acetonitrile to phosphate buffer 18:82). The injection volume is 2 μL, and the detection wavelength is 245 nm. The results are as follows: Figure 3 As shown in Table 2: Table 2

[0033] from Figure 3 As shown in Table 2, the monosaccharides of this Agaricus bisporus enzyme-extracted polysaccharide are composed of arabinose, rhamnose, galactose, mannose, and galacturonic acid. Among them, galacturonic acid accounts for the highest proportion at 38.06%, followed by galactose at 27.66% and arabinose at 22.98%. Rhamnose and mannose account for a relatively low proportion, at 3.39% and 3.24%, respectively. The high proportion of galacturonic acid also indicates that this polysaccharide is an acidic polysaccharide with a rich variety of monosaccharides and significant differences in the molar proportion of each monosaccharide.

[0034] Test Example 4 Take 2 mg of the polysaccharide extracted from Agaricus bisporus in Example 1, prepare tablets using the KBr compression method, and analyze them using a Fourier transform infrared spectrometer at 4000 cm⁻¹. -1 -500cm -1 Detection was performed within the wavenumber range, and infrared spectra were acquired. The results are as follows: Figure 4 As shown. From Figure 4 It can be seen that the polysaccharide extracted from this Agaricus bisporus exhibits a series of typical infrared characteristic absorption peaks for polysaccharides, with a peak height of 3293.70 cm⁻¹. -1 The strong and broad absorption peak at 2931.79 cm⁻¹ is attributed to the OH stretching vibration, a characteristic signal of the hydroxyl groups in polysaccharides, indicating that the polymer contains a large number of hydroxyl groups; -1 The absorption peak corresponds to the saturated CH stretching vibration, indicating that the polysaccharide molecule has a saturated alkyl side chain structure; 1738.21 cm⁻¹ -1 The absorption peak at 1609.25 cm⁻¹ corresponds to the C=O stretching vibration of the carboxyl group in uronic acid, directly proving that the sample contains a uronic acid structure. -1 The absorption peak is attributed to the carboxyl bending vibration, which can superimpose with the absorption of bound water, further confirming the presence of the acidic uronic acid component; 1410.82 cm⁻¹ -1 1328.26cm-1 The CH bending vibrations of methyl and methylene groups again reflect the intramolecular saturated hydrocarbon side chain structure; 1141.36 cm⁻¹ -1 1071.86cm -1 1014.81cm -1 This is a characteristic absorption of polysaccharides, corresponding to the COC glycosidic bond and the stretching vibration of the COH, confirming that the tested sample belongs to a polysaccharide compound; 911.85 cm⁻¹ -1 -535.50cm -1 Multiple absorption signals in the fingerprint region originate from the bending vibrations of the sugar ring backbone and glycosidic bonds, which can be used to characterize the structural features of the sugar ring and glycosidic bonds of this polysaccharide.

[0035] Test Example 5 Thirty 5-week-old male C57BL / 6J mice (purchased from Beijing Vital River Laboratory Animal Technology Co., Ltd.) were selected. The experimental feed was purchased from Jiangsu Xietong Pharmaceutical Biotechnology Co., Ltd., China, with an energy composition of 22.9% protein, 11.1% fat, and 66% carbohydrates. The mice were housed in an SPF-grade animal laboratory with a 12-hour light-dark cycle, an ambient temperature of 23±2℃, and a humidity of 55%±5%. The mice had free access to food and water. After one week of acclimatization, they were randomly divided into a normal group, a model group, and a polysaccharide group, with 10 mice in each group. Except for the normal group, [the following groups were used for further research]. The other two groups of mice were subjected to two repetitive, unpredictable stressors daily. These stressors included wet bedding, no bedding, restraint, cage tilting, tail clamping, fasting, water deprivation, and cage shaking. An average of two stressors were applied daily for 8 weeks. During the modeling period, the normal and model groups were administered physiological saline by gavage, while the polysaccharide group was administered the Agaricus bisporus enzyme-extracted polysaccharide solution from Example 1 by gavage at a dose of 200 mg / kg / day. Mouse weight, food intake, and water intake were continuously recorded throughout the experiment. After the modeling period, the mice were dissected, and the liver, spleen, and kidneys were harvested, weighed, and organ indices were calculated. The results are as follows: Figure 5 As shown. From Figure 5 It can be seen that after 8 weeks of chronic unpredictable mild stress modeling, the body weight of mice in the model group was significantly lower than that in the normal group. However, the intervention of gavage with button mushroom enzyme-extracted polysaccharide in the polysaccharide group significantly alleviated the trend of body weight loss in the model mice. There were no significant differences in food intake and water intake among the groups, indicating that the modeling and polysaccharide intervention did not cause changes in body weight by affecting feeding and drinking behavior. At the same time, there were no significant abnormal changes in liver index, spleen index, and kidney index among the normal group, model group, and polysaccharide group, and no organ damage-related manifestations were observed. This indicates that the dosage used in this experiment for chronic unpredictable mild stress modeling and gavage intervention with button mushroom enzyme-extracted polysaccharide did not produce significant organ toxicity to the liver, spleen, and kidneys of mice, confirming that the button mushroom enzyme-extracted polysaccharide has good in vivo safety.

[0036] Test Example 6 Mice in the normal group, model group, and polysaccharide group underwent an open field test. Mice were placed in a well-insulated, temperature- and humidity-controlled environment for 1 hour to acclimatize. After 1 hour, the mice were placed in the center of the bottom of an open field chamber, and their activities were recorded for the next 10 minutes using a camera. VisuTrack animal behavior software was used to analyze the mice's behavior. Before each open field test, the chamber was disinfected and odor removed with 75% medical alcohol. The total distance the mice moved within 10 minutes and the distance they moved in the central area were recorded. The time spent in the central area and the distance they moved were inversely proportional to their anxiety level. The results are as follows: Figure 6 As shown. From Figure 6 It can be seen that, compared with the normal group, the total movement distance of mice in the model group after chronic unpredictable mild stress treatment was significantly reduced, and the movement distance in the central area was also significantly reduced. Combined with the open field test heat map, it can be seen that the mice in the model group preferred to move in the edge area of ​​the box and rarely entered the central open area, showing significant anxiety-like behavior. However, the total movement distance and the movement distance in the central area of ​​the polysaccharide group after intervention with Agaricus bisporus enzyme extract polysaccharide were significantly increased compared with the model group, and the mice's exploration activities in the central area were significantly restored. This indicates that Agaricus bisporus enzyme extract polysaccharide can effectively improve the spontaneous activity level of mice in chronic stress model and alleviate the anxiety-related behaviors induced by chronic stress in mice.

[0037] Test Example 7 Mice in the normal group, model group, and polysaccharide group underwent an elevated cross maze test. Mice were placed in a dark environment for 1 hour to acclimatize. The elevated cross maze device was 45 cm high, consisting of two closed arms and two open arms. Each arm was 66 cm long and 10 cm wide, with a closed arm wall height of 30 cm and a central intersection area of ​​10 × 10 cm. Mice were placed in the central intersection area and allowed to explore freely for 6 minutes. After each test, the maze was wiped with 70% ethanol to remove residual odor. The number of times mice entered the open arms and the time spent in the open arms were recorded. The results are as follows: Figure 7 As shown. From Figure 7 It can be seen that, compared with the normal group, the number of times mice entered the open arm and the time spent in the open arm were significantly reduced in the model group mice after 8 weeks of chronic unpredictable mild stress modeling. The heat map of the elevated cross maze also showed that the model group mice entered the open arm area less often and their main activities were concentrated in the closed arm, showing significant anxiety-like behavior. After intervention with Agaricus bisporus enzyme-extracted polysaccharide, the number of times mice entered the open arm and the time spent in the open arm were significantly increased compared with the model group. The heat map also reflected that the exploration behavior of the mice in the open arm was restored in the polysaccharide group. This indicates that Agaricus bisporus enzyme-extracted polysaccharide can effectively reverse the anxiety-like behavior induced by chronic stress in mice, enhance the mice's willingness to explore the open arm area, and exert an anti-anxiety effect.

[0038] Test Example 8 Mice in the normal group, model group, and polysaccharide group underwent the following tests in sequence: sucrose preference test, tail suspension test, and forced swimming test. (1) Sugar water preference experiment: The experiment was divided into two stages: adaptation training and testing. During the adaptation training stage, two bottles of 1% (w / v) sucrose solution were placed in each rat cage. After 24 hours, one of the bottles was replaced with pure water. After 12 hours, the positions of the two bottles were switched, and the adaptation training was completed after another 12 hours. The mice were then fasted and deprived of water for 24 hours. After that, a bottle of 1% (w / v) sucrose solution and a bottle of pure water were placed in the rat cage at the same time. The preference test was carried out for 12 hours under the fasting condition. The consumption of sucrose solution and pure water was recorded, and the sugar water preference rate was calculated: Sugar water preference rate = consumption of sucrose solution / (consumption of sucrose solution + consumption of pure water). (2) Tail suspension test: The tail of the mouse was suspended by tape so that it could not escape. The total test time was 6 minutes. The first 2 minutes were the adaptation period. The time the mouse remained still in the last 4 minutes was recorded. The longer the still time, the more significant the depressive-like behavior. (3) Forced swimming test: Mice were placed in a cylindrical container with a diameter of 10 cm and a height of 25 cm. The container was filled with water to a depth of 19 cm, and the water temperature was maintained at 25 ± 1 ℃. The test lasted for a total of 5 minutes. The first 2 minutes were recorded as the time the mice remained still for the first time. The time the mice remained still in the water for the last 3 minutes was recorded. The state of stillness was defined as the mice maintaining only the necessary action of keeping their heads above the water. After the test, the mice were dried and returned to their cages. The stillness time was recorded using video recording and behavioral software. The longer the stillness time, the higher the degree of depression. The results are as follows: Figure 8 As shown.

[0039] from Figure 8 It can be seen that, compared with the normal group, the sucrose preference rate of mice in the model group after chronic unpredictable mild stress modeling was significantly reduced. The sucrose preference rate in the model group was 78.18%, significantly lower than the 91.47% in the normal group. Simultaneously, the immobility time in the tail suspension test of the model group mice reached 197.17s and the immobility time in the forced swimming test reached 164.39s, both significantly higher than the corresponding immobility times of 136.47s and 109.44s in the normal group, suggesting that the model group mice exhibited significant anhedonia and depressive-like behavioral characteristics such as behavioral despair. After intervention with mushroom enzyme-extracted polysaccharides, the sugar water preference rate of mice in the polysaccharide group rebounded to 85.20%, significantly higher than that in the model group. The immobility time in tail suspension decreased to 134.72s, and the immobility time in forced swimming decreased to 120.90s. Both immobility time indicators were significantly lower than those in the model group, indicating that mushroom enzyme-extracted polysaccharides can improve the loss of pleasure in mice caused by chronic stress, reduce the degree of despair in mice, and effectively reverse the depressive-like behavior induced by chronic unpredictable mild stress. These results suggest that mushroom enzyme-extracted polysaccharides have good application potential in the development of anti-anxiety and antidepressant drugs or foods.

[0040] Obviously, the above embodiments are merely illustrative examples for clear explanation and are not intended to limit the implementation. Those skilled in the art will recognize that other variations or modifications can be made based on the above description. It is neither necessary nor possible to exhaustively list all possible implementations here. However, obvious variations or modifications derived therefrom are still within the scope of protection of this invention.

Claims

1. A method for preparing polysaccharides extracted from Agaricus bisporus, characterized in that, Includes the following steps: S1. Disperse the button mushroom ultrafine powder in water, first add cellulase and xylanase for the first stage of enzymatic hydrolysis, then add heat-resistant α-propanase. Amylase was used for the second stage of enzymatic hydrolysis, then papain was added for the third stage of enzymatic hydrolysis and enzyme inactivation, followed by the addition of saccharifying enzyme for the fourth stage of enzymatic hydrolysis and enzyme inactivation again, and centrifugation was used to obtain the Agaricus bisporus complex enzyme extract. S2. The Agaricus bisporus complex enzyme extract described in S1 is concentrated by rotary evaporation. Ethanol is added dropwise under stirring to the first ethanol volume concentration. After standing, the supernatant is collected by centrifugation. Ethanol is added to the supernatant to the second ethanol volume concentration. After standing, the precipitate is collected by centrifugation. The precipitate is reconstituted with pure water and then dialyzed, concentrated under reduced pressure, and freeze-dried to obtain Agaricus bisporus enzyme extract crude polysaccharide. S3. The crude polysaccharide extracted from the button mushroom by enzymes in S2 is subjected to gradient elution on a cellulose column and water elution on a dextran gel column, and then freeze-dried to obtain the enzyme-extracted polysaccharide from the button mushroom.

2. The method for preparing Agaricus bisporus enzymatically extracted polysaccharide according to claim 1, characterized in that, In S1, the mass-to-volume ratio of the Agaricus bisporus ultrafine powder to water is (9-11) g: (280-320) mL; And / or, the pH of the enzymatic hydrolysis system is 4-6.

3. The method for preparing Agaricus bisporus enzymatically extracted polysaccharide according to claim 1, characterized in that, In S1, the amount of cellulase and xylanase used is independently 950 U / g-1050 U / g of Agaricus bisporus ultrafine powder; And / or, the temperature of the first stage of enzymatic hydrolysis is 55℃-65℃, and the time is 2.5h-3.5h; And / or, the amount of the heat-resistant α-amylase used is 4.5 μL / g to 5.5 μL / g of Agaricus bisporus ultrafine powder; And / or, the temperature for the second stage of enzymatic hydrolysis is 75℃-85℃, and the time is 0.5h-1.5h; And / or, the amount of papain used is 4.5 μL / g to 5.5 μL / g of Agaricus bisporus ultrafine powder; And / or, the temperature of the third stage of enzymatic hydrolysis is 55℃-65℃, and the time is 0.5h-1.5h; And / or, the amount of the saccharifying enzyme used is 48 μL / g-52 μL / g of Agaricus bisporus ultrafine powder; And / or, the fourth stage of enzymatic hydrolysis is carried out at a temperature of 55℃-65℃ for a time of 2.5h-3.5h.

4. The method for preparing Agaricus bisporus enzymatically extracted polysaccharide according to claim 1, characterized in that, In S1, the enzyme inactivation temperature is 95℃-105℃, and the time is 9min-11min; And / or, the temperature for the second enzyme inactivation is 95℃-105℃, and the time is 9min-11min.

5. The method for preparing Agaricus bisporus enzymatically extracted polysaccharide according to claim 1, characterized in that, In S2, the rotary evaporation concentration is to concentrate to 1 / 4 to 1 / 6 of the original volume; And / or, the volume concentration of the first ethanol is 8%-12%; And / or, the volume concentration of the second ethanol is 65%-75%; And / or, the dialysis is performed using a dialysis bag with a molecular weight cutoff of 3000 Da-4000 Da, first dialyzing with flowing water for 1.5-2.5 days, and then dialyzing with ultrapure water for 0.5-1.5 days.

6. The method for preparing Agaricus bisporus enzymatically extracted polysaccharide according to claim 1, characterized in that, In S3, the cellulose column is a DEAE-52 cellulose ion exchange column; And / or, the gradient elution is performed sequentially with water, 0.25 mol / L sodium chloride solution, 0.5 mol / L sodium chloride solution, and 1 mol / L sodium chloride solution, at a flow rate of 0.6 mL / min-0.8 mL / min and a time of 380 min-420 min.

7. The method for preparing Agaricus bisporus enzymatically extracted polysaccharide according to claim 1, characterized in that, In S3, the dextran gel column is a Sephacryl-100 dextran gel column; And / or, the water elution flow rate is 0.6 mL / min-0.8 mL / min, and the time is 450 min-550 min.

8. The Agaricus bisporus enzyme-extracted polysaccharide prepared by the method according to any one of claims 1-7, characterized in that, The molecular weight of the polysaccharide extracted from Agaricus bisporus is 80kDa-95kDa, and the polydispersity index is 1.0-1.

2.

9. The Agaricus bisporus enzyme-extracted polysaccharide according to claim 8, characterized in that, The polysaccharide extracted from Agaricus bisporus includes: 21wt%-24wt% arabinose, 3wt%-4wt% rhamnose, 26wt%-29wt% galactose, 3wt%-4wt% mannose, and 36wt%-40wt% galacturonic acid.

10. The use of the mushroom spawn polysaccharide as described in any one of claims 8-9 in the preparation of a medicine or food for the prevention or treatment of depression.